Frequently Asked Questions

How can I get involved in E2P?

You can sign up here to contribute to the development and testing of the tools, to learn more about incorporating E2P tools into your primary care practice, or to discuss whether your hospital could participate in the program. 

What platforms are E2P tools available on?

E2P tools will initially be developed for the following platforms:  

  • Primary care: Telus PS Suite, Accuro QHR, and OSCAR Electronic Medical Record (EMR).  
  • Acute care: Cerner, EPIC, and Meditech Hospital Information Systems (HIS). 
What change management supports are available for clinicians?

Change management supports will assist clinicians to integrate evidence-based tools into their workflows and provide guidance on how to optimize use at the point of care.   

In primary care, clinicians and organizations have access to:  

  • Tailored, individualized supports to enable meaningful implementation and adoption.  
  • Change management specialists from the eHealth Centre of Excellence to support installation and provide training.  
  • Academic detailing service with a trained clinical pharmacist from CEP to support users with applying the evidence in their local practice.   

In acute care, hospital sites have access to:  

  • Change management specialists from North York General Hospital. 
  • Predeveloped materials, supports and resources to support enhancement development, implementation, and clinician training. 
  • A train the trainer model to build internal capacity. 
What is the timeframe of E2P?

E2P was initiated in 2021 and is funded until the end of the 2024 fiscal year. Tools and supports will be available for heart failure (launched in late 2022) anxiety disorders and major depression in adults (spring 2023), and type 2 diabetes (summer 2023). Once launched, E2P partners will expand uptake of the use cases across the province.   

How were topics chosen?

To identify potential topics, the E2P team scanned existing quality standards, gathered evidence about barriers and enablers, consulted clinicians and stakeholders, and leveraged partner experience and knowledge of the health system context and priorities. 

Four priority areas emerged – heart failure, anxiety disorders, major depression and prediabetes/type 2 diabetes – and were confirmed by the E2P steering committee.

How is E2P addressing health equity?

E2P’s vision is a future where all Ontarians receive the best evidence-based care, regardless of where they live or receive care. We will do this by supporting clinicians with easy-to-use tools and supports at the point of care. E2P partners are committed to applying a health equity approach with an anti-oppression and anti-racism lens and are working to embed these considerations into program design, processes, and outcomes where possible.  

How will E2P be evaluated? How will evaluation results be reflected in the development of tools and supports?

E2P is taking a learning health system approach including both formative and summative evaluation. 

  • Formative evaluation will be conducted by E2P partners on an ongoing basis, enabling continuous learning about implementation and program quality, and will drive program adaptations and improvement. 
  • Summative impact evaluation will be conducted by a third-party evaluator and will explore the impact of deployed solutions across populations. Initial results will be available March 2024.